These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 9524835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J, Söderquist B, Normark BH, Norrby-Teglund A.
    Clin Infect Dis; 2004 Mar 15; 38(6):836-42. PubMed ID: 14999628
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.
    Norrby-Teglund A, Kaul R, Low DE, McGeer A, Newton DW, Andersson J, Andersson U, Kotb M.
    J Immunol; 1996 Apr 15; 156(8):3057-64. PubMed ID: 8609429
    [Abstract] [Full Text] [Related]

  • 6. Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release.
    Davies FJ, Olme C, Lynskey NN, Turner CE, Sriskandan S.
    Clin Exp Immunol; 2019 Jul 15; 197(1):83-94. PubMed ID: 30815853
    [Abstract] [Full Text] [Related]

  • 7. Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.
    Basma H, Norrby-Teglund A, McGeer A, Low DE, El-Ahmedy O, Dale JB, Schwartz B, Kotb M.
    Infect Immun; 1998 May 15; 66(5):2279-83. PubMed ID: 9573118
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin.
    Yanagisawa C, Hanaki H, Natae T, Sunakawa K.
    J Infect Chemother; 2007 Dec 15; 13(6):368-72. PubMed ID: 18095084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Superantigens and streptococcal toxic shock syndrome.
    Proft T, Sriskandan S, Yang L, Fraser JD.
    Emerg Infect Dis; 2003 Oct 15; 9(10):1211-8. PubMed ID: 14609454
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.